Publications by authors named "Peter Kyriakou"

Claim this Profile
I
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory.
Eloise Williams, Katherine Bond, Brian Chong, Dawn Giltrap, Malcolm Eaton, Peter Kyriakou

Pathology· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health service impact of testing for respiratory pathogens using cartridge-based multiplex array versus molecular batch testing.
Victoria M Madigan, Vincent G Sinickas, Dawn Giltrap, Peter Kyriakou, Katherine Ryan

Pathology· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma.
Bruce E Loveland, Anne Zhao, Shane White, Hui Gan, Kate Hamilton, Peter Kyriakou

Clin Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
Bruce E Loveland, Julie Milland, Peter Kyriakou, Bruce R Thorley, Dale Christiansen

Xenotransplantation· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus.
Dale Christiansen, Emmanuel R De Sousa, Bruce Loveland, Peter Kyriakou, Marc Lanteri

J Gen Virol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis